Publications by authors named "Giacomo Zuccarini"
Metformin/glibenclamide-related interstitial lung disease: a case report.
Sarcoidosis Vasc Diffuse Lung Dis
July 2014
Article Synopsis
- Interstitial lung disease (ILD) can be caused by various drugs, but reports linking it to oral hypoglycemic medications are rare.
- A 78-year-old diabetic woman experienced symptoms of ILD while taking metformin and glibenclamide, and her condition improved after switching to insulin therapy.
- This case emphasizes the need for clinicians to consider medications as potential causes in patients with suspected ILD, highlighting the emerging recognition of drug-related lung toxicity.
In recent years Tumor Necrosis Factor alpha (TNF alfa) inhibitors have been highly effective in treating rheumatoid arthritis (RA). However, patients receiving these inhibitors have an increased risk of developing tuberculosis (TB). We describe a rare case of tuberculosis of the tongue in an RA patient treated with methotrexate (MTX) and the TNF alfa inhibitor adalimumab (ADA) for the previous six years.
View Article and Find Full Text PDF